Topic Highlight Open Access
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 21, 2011; 17(27): 3198-3203
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3198
From intestinal stem cells to inflammatory bowel diseases
Michael Gersemann, Eduard Friedrich Stange, Jan Wehkamp, Internal Medicine I, Robert Bosch Hospital, Auerbachstrasse 110, D-70376 Stuttgart, Germany
Michael Gersemann, Eduard Friedrich Stange, Jan Wehkamp, Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology and University of Tübingen, Auerbachstrasse 112, D-70376 Stuttgart, Germany
Author contributions: Gersemann M, Stange EF and Wehkamp J have been researching the pathogenesis of Crohn’s disease and ulcerative colitis for many years. This review article was a joint work.
Supported by The Robert Bosch Foundation, Stuttgart, Germany and the Emmy Noether program (Wehkamp J) of the Deutsche Forschungsgemeinschaft (DFG)
Correspondence to: Michael Gersemann, MD, Internal Medicine I, Robert Bosch Hospital, Auerbachstrasse 110, D-70376 Stuttgart, Germany. michael.gersemann@rbk.de
Telephone: +49-711-81015912 Fax: +49-711-81013793
Received: December 10, 2010
Revised: February 9, 2011
Accepted: February 16, 2011
Published online: July 21, 2011

Abstract

The pathogenesis of both entities of inflammatory bowel disease (IBD), namely Crohn’s disease (CD) and ulcerative colitis (UC), is still complex and under investigation. The importance of the microbial flora in developing IBD is beyond debate. In the last few years, the focus has changed from adaptive towards innate immunity. Crohn’s ileitis is associated with a deficiency of the antimicrobial shield, as shown by a reduced expression and secretion of the Paneth cell defensin HD5 and HD6, which is related to a Paneth cell differentiation defect mediated by a diminished expression of the Wnt transcription factor TCF4. In UC, the protective mucus layer, acting as a physical and chemical barrier between the gut epithelium and the luminal microbes, is thinner and in part denuded as compared to controls. This could be caused by a missing induction of the goblet cell differentiation factors Hath1 and KLF4 leading to immature goblet cells. This defective Paneth and goblet cell differentiation in Crohn’s ileitis and UC may enable the luminal microbes to invade the mucosa and trigger the inflammation. The exact molecular mechanisms behind ileal CD and also UC must be further clarified, but these observations could give rise to new therapeutic strategies based on a stimulation of the protective innate immune system.

Key Words: Inflammatory bowel disease; Paneth cells; Goblet cells; Cell differentiation; TCF4; Hath1; KLF4



INTRODUCTION

Crohn’s disease (CD) and ulcerative colitis (UC) are the 2 main entities of inflammatory bowel disease (IBD). Whereas CD mostly involves the distal ileum and/or the colon, the inflammation in UC is restricted to the colon. Since both disease locations are characterized by a high concentration of intestinal bacteria (107-108 organisms/g luminal content in the distal ileum and 1011-1012 in the colon), it is not surprisingly that these luminal microbes are playing an important role in the development of IBD (see our review in the World Journal of Gastroenterology[1]). In healthy mucosa, these microbes are sufficiently controlled by an adequate secretion of antimicrobial peptides and by the mucus layer, acting as a physical and chemical barrier (Figure 1A). Even if the pathogenesis of both forms of IBD is still under investigation, the last few years have revealed evidence that the differentiation from the intestinal stem cell towards the Paneth cell in ileal CD and towards the goblet cell in UC may be disturbed. This may result in a defective antimicrobial and mucus barrier, which enables the intestinal bacteria to invade the mucosa and trigger the inflammation. In this review, we focus on the intestinal stem cells, their differentiation towards Paneth and goblet cells, and the defective antimicrobial shield in ileal CD and mucus layer in UC as a consequence of a stem cell differentiation defect.

Figure 1
Figure 1 Proposed model for the pathogenesis of ileal Crohn’s disease and ulcerative colitis. A: In the healthy ileal and colonic mucosa, luminal microbes are sufficiently controlled by an adequate secretion of antimicrobials peptides and a sufficient mucus layer; B: In ileal Crohn’s disease, defective Paneth cell differentiation mediated by a reduction of the Wnt transcription factor TCF4 leads to a decreased Paneth cell defensin secretion, especially in case of NOD2 mutations. This allows the luminal microbes to attach and invade in the mucosa causing inflammation; C: In ulcerative colitis, a defective goblet cell differentiation based on a missing induction of the transcription factors Hath1 and KLF4 results in mucus deficiency enabling the luminal microbes to invade the mucosa and trigger inflammation.
INTESTINAL STEM CELLS AND THEIR MARKERS

The whole intestinal tract is a rapidly self-renewing tissue maintained by a population of intestinal stem cells. For many decades, scientists tried to identify these relatively undifferentiated enigmatic cells - unfortunately with limited success due to a lack of good cellular markers. Nevertheless, about 30 years ago, 2 models were established concerning intestinal stem cell location in the human gut, which are still debated. The first hypothesis is called the “+4 position model”. It assumes the intestinal stem cells to be located above the Paneth cells at position +4 relative to the crypt base[2]. The second hypothesis, also called the “stem cell zone model”, proposed that the crypt base columnar cells, a cell population at the bottom of the crypt, represent the intestinal stem cells[2]. Both models suggest that about 6 intestinal stem cells are found in each crypt[2], surrounded by epithelial and mesenchymal cells regulating stem cell behavior[3].

The intestinal stem cells differentiate into 4 epithelial cell types[3]. The most abundant cells in the epithelium are the columnar cells. Their main function is the absorption of nutrients by apical microvilli. Goblet cells produce and secrete mucins in order to form a protective luminal mucus layer. Neuroendocrine cells release hormones in an endocrine and paracrine fashion. Finally, the Paneth cells, located in the crypt base of the small intestine and ascending colon secrete defensins and other antimicrobial peptides to keep the crypts sterile[4].

In 2007, Hans Clevers and his group found the Wnt target gene leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5) to be expressed in cells at the crypt base[5]. Furthermore, irreversible labeling of these cells revealed, that all 4 epithelial cell types (columnar cells, goblet cells, Paneth cells and neuroendocrine cells) arise from these cells. Since LGR5-positive cells are located at the crypt base, are pluripotent and also self-renewing, they concluded that LGR5 is a good marker for the intestinal stem cells[5]. In 2009, the same group found olfactomedin 4 (also known as OLFM4, hGC1 or GW112), a protein with unknown function, to be a robust and specific marker for these LGR5 stem cells in the human intestine[6].

Intestinal stem cells are regulated by several cell signaling pathways, including the Wnt and Notch pathway[7,8]. Defects in these pathways are known to be related to the development of intestinal cancer[3,8,9]. The role of stem cell differentiation towards Paneth cells in ileal CD and towards goblet cells in UC is a new and promising field of science which could contribute to a better understanding of these 2 diseases[10,11].

DEFECTIVE PANETH CELL DIFFERENTIATION IN ILEAL CD IS RELATED TO α-DEFENSIN DEFIENCY

Paneth cells were first described more than 100 years ago as granular cells at the base of the intestinal crypts of Lieberkühn[12]. About 5-12 Paneth cells can be found in each small intestinal crypt and, in contrast to columnar cells, goblet cells and neuroendocrine cells, they do not migrate upwards in the crypt but remain beneath or between the stem cells in the crypt base[13]. Their numerous apical cytoplasmic granula are filled with antimicrobial peptides, especially the α-defensins HD5 and HD6, but also other antimicrobials such as lysozyme and phospholipase A2[14]. These Paneth cell defensins, which are active against a large number of microbes, including Gram-positive and Gram-negative bacteria, fungi and viruses[15], can be released into the crypt lumen in order to regulate the microbial density and therefore protect the intestinal epithelium against bacterial invasion and inflammation.

Paneth cells derive from intestinal stem cells under the control of the Wnt signaling pathway. In particular, the Wnt transcription factor TCF4 is essential in Paneth cell differentiation, as shown in the embryonic mouse intestine[16]. After the activation of Wnt signaling, an intracellular β-catenin-TCF4-complex is formed and translocates into the nucleus, where the compound acts as a transcription factor controlling the expression of several downstream target genes, such as Paneth cell defensins. This was shown in TCF4 null mice, where TCF4 regulates the expression of the cryptids (the mouse homologs to the human α-defensins)[16].

This Paneth cell differentiation factor TCF4 was found to be reduced in ileal CD as compared to colonic CD and colonic UC[10]. Interestingly, this observation was independent of the degree of inflammation and independent of the NOD2 genotype[10]. In human samples HD5 and HD6 expression correlated well with TCF4, thus it seems that not only in animal models, but also in humans, Paneth cell defensins are regulated by TCF4[10]. The functional relevance of this TCF4 decrease was shown in TCF4 knockout mice: the reduced TCF4 expression apparently resulted in a decreased HD5 and HD6 expression[10]. Moreover, we found a high affinity binding site in the HD5 and HD6 promotor for TCF4, and notably, we detected genetic variants in the putative promoter region of the Wnt transcription factor TCF4 (TCF7L2) to be associated with ileal CD[17]. This genetic finding emphasizes the primary role of the TCF4 defect in CD.

This also explains in part why in ileal CD, but not in colonic CD or UC, and also not in pouchitis samples, we had found a decreased expression of the α-defensins HD5 and HD6[14,18]. The other Paneth cell products were unchanged or even increased as compared with control samples[14]. This observation was independent of the degree of inflammation[14,18], and even more pronounced in patients with NOD2 mutations[14,18], which are clearly associated with ileal CD[19,20]. This is interesting, since

Kobayashi et al[21] found NOD2-deficient mice to be susceptible to bacterial infection and, in addition, NOD2 seems to be essential for the expression of cryptdins. Elphick et al[22] confirmed this low defensin formation in ileal CD especially in those with a NOD2 mutation. Another study showed the same low defensin synthesis in CD but linked it to inflammation and loss of Paneth cells[23]. In contrast to this observation, Kelly et al[24] and also our group found an unaltered number of Paneth cells in ileal CD[14]. We were also able to demonstrate a reduced antibacterial activity in mucosal extracts from patients with ileal CD suggesting that the missing expression of Paneth cell defensins in humans leads to a defective antimicrobial shield[14]. Since transgenic mice with human HD5 expression had an abnormal composition of the luminal microbial flora, it seems plausible that Paneth cell defensins can influence the makeup of the bacterial flora[14].

Taken together, the defective differentiation from the intestinal stem cell towards the Paneth cell is mediated by a diminished expression of the Wnt signaling transcription factor TCF4 resulting in a specific deficiency of the Paneth cell defensins in humans, especially in case of NOD2 mutations. This leads to a dysfunction of the mucosal barrier, which enables the luminal microbes to invade the mucosa and cause inflammation (Figure 1B). Besides the genetic link of TCF4 to ileal CD, other molecules, such as NOD2, ATG16L1, XBP1, KCNN4 and HD5 are genetically defective in ileal CD. As all these molecules are necessary for Paneth cell function, it seems to be plausible that the decrease in Paneth cell α-defensins is a primary (genetic) factor in disease pathogenesis[17,25].

IMPAIRED GOBLET CELL DIFFERENTIATION IN UC IS LINKED TO A DEFECTIVE MUCUS LAYER

Goblet cells are glandular epithelial cells scattered among the absorptive cells in the epithelium. The cytoplasm of these cells is filled with granula containing mucins, which are secreted into the intestinal lumen. These mucins form the mucus layer, acting as a barrier between the luminal contents and the epithelial surface[26].

Goblet cells derive from intestinal stem and progenitor cells located in the lower part of the crypt. Their differentiation is controlled by several transcription factors, especially by the basic helix-loop-helix transcription factor Hath1, the zinc-finger transcription factor KLF4 and the Notch target gene Hes1. For example, Math1 null mice (Math1 is the mouse homologe of human Hath1) are not able to develop goblet cells, whereas the columnar cells are intact[27]. In accordance to Hath1, goblet cell differentiation was also defective in KLF4 null mice as shown by a decrease of about 90% of colonic goblet cells in these mice[28]. Hath1 seems to be involved in an early stage of goblet cell differentiation, KLF4 appears to play a crucial role especially in the terminal stage of goblet cell differentiation[28]. In contrast, the genetic knockout of Hes1 gives rise to an increased number of goblet cells accompanied by a reduced number of nonsecretory cells[27,29,30], suggesting that Hes1 is a antagonist of Hath1[31]. In particular, the balance between Hath1 and Hes1 seems to be essential in controlling goblet cell differentiation in the epithelium, at least in the small intestine[31].

In 2009, we investigated these 3 crucial goblet cell differentiation factors in IBD. We found a significant induction of the goblet cell differentiation factors Hath1 and KLF4 in noninflamed vs inflamed CD, but not in UC[11]. Particularly in inflamed CD, the expression of Hath1 and KLF4 was about twice as high as that in inflamed UC samples[11]. For Hath1, these mRNA data were confirmed on the protein level by immunohistochemistry and Western blotting. Interestingly, this attenuated induction of Hath1 and KLF4 in UC was independent of the degree of inflammation and seems not to result from a downregulation by increased Notch activity[11]. Hes1 expression was also augmented in inflamed CD as compared to inflamed UC, but without reaching significance[11].

In contrast to CD, the expression of the colonic antimicrobials is increased in inflamed UC suggesting that the antimicrobial shield is intact in these patients[32-34]. Nevertheless, the colonic mucus layer, which cover the whole gastrointestinal tract and act as a physical and chemical barrier against the luminal microbes, is altered and even deficient in UC[35-37]. The thickness of the mucus layer in the healthy colon was measured between 100 and 300 μm, increasing from the ascending colon to the rectum[36,38,39], whereas in UC, this mucus layer is thinner, more variable and in part denuded[35,36].

Since the “raison d’être” of goblet cells is to secrete mucus, it is not surprising that a decrease of the mature goblet cells, located in the upper part of the crypts, was found in UC compared with controls[11]. Moreover, in our samples the expression of the main colonic mucins (Muc1, 2 and 4) tended to increase in inflamed IBD, whereas this induction was clearly less pronounced in inflamed UC compared with inflamed CD[11]. Since Hath1 and KLF4 were also highly correlated with these mucins, it is possible that the defective mucus layer in UC is related to these 2 differentiation factors[11].

Overall, the defective differentiation from intestinal stem cells towards goblet cells, which is mediated by the 2 crucial transcription factors Hath1 and KLF4, may lead to goblet cell depletion and deficient mucin induction in active UC. This could explain the defective mucus barrier in UC, resulting in a collapse of the physical barrier, which enables the luminal microbes to invade the mucosa and trigger inflammation (Figure 1C). The role of mucins in host defense was shown by MUC2-deficient mice which spontaneously develop colitis[40]. As Swidsinski et al[41] found high concentrations of mucosal bacteria in patients with IBD, and as kationic defensins bind to the negatively charged mucins[42], we hypothesize that in UC the mucosa is not capable of holding back the fecal bacteria based on a defective mucus layer which is unable to bind the adequate amounts of secreted defensins.

CONCLUSION

The pathogenesis of IBD is certainly complex and still under investigation. Nevertheless, ileal CD and colonic UC are associated with defects in stem cell differentiation either to protective Paneth cells or goblet cells. Diminished Paneth cell defensins result in a defective antimicrobial barrier in ileal CD, whereas in UC, an insufficient induction of goblet cell mucins can lead to a disturbed mucosal barrier. In both cases, luminal microbes are allowed to invade the mucosa and cause inflammation. New therapeutic strategies should focus on a stimulation of the antimicrobial shield in ileal CD and stabilization of the mucus layer in UC.

Footnotes

Peer reviewers: Jürgen Büning, MD, Internal Medicine I, Department of Gastroenterology, University Hospital of Schleswig-Holstein, Ratzeburger Allee 160, D-23538 Lübeck, Germany; Daniel S Straus, PhD, Professor, Biomedical Sciences Division, University of California, Riverside, CA 9252, United States; Ki-Baik Hahm, MD, PhD, Professor, Gachon Graduate School of Medicine, Department of Gastroenterology, Lee Gil Ya Cancer and Diabetes Institute, Lab of Translational Medicine, 7-45 Songdo-dong, Yeonsu-gu, Incheon, 406-840, South Korea

S- Editor Tian L L- Editor Cant MR E- Editor Zheng XM

References
1.  Gersemann M, Wehkamp J, Fellermann K, Stange EF. Crohn's disease--defect in innate defence. World J Gastroenterol. 2008;14:5499-5503.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Haegebarth A, Clevers H. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol. 2009;174:715-721.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Leedham SJ, Brittan M, McDonald SA, Wright NA. Intestinal stem cells. J Cell Mol Med. 2005;9:11-24.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Ouellette AJ. Defensin-mediated innate immunity in the small intestine. Best Pract Res Clin Gastroenterol. 2004;18:405-419.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003-1007.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137:15-17.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Crosnier C, Stamataki D, Lewis J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet. 2006;7:349-359.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Katoh M, Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol. 2007;30:247-251.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Bach SP, Renehan AG, Potten CS. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis. 2000;21:469-476.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Wehkamp J, Wang G, Kübler I, Nuding S, Gregorieff A, Schnabel A, Kays RJ, Fellermann K, Burk O, Schwab M. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol. 2007;179:3109-3118.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Gersemann M, Becker S, Kübler I, Koslowski M, Wang G, Herrlinger KR, Griger J, Fritz P, Fellermann K, Schwab M. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation. 2009;77:84-94.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Paneth J. Über die sezernierenden Zellen des Dünndarm-Epithels. Archiv für mikroskopische Anatomie. 1888;31:113-192.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, Gordon JI. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci USA. 1994;91:10335-10339.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA. 2005;102:18129-18134.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710-720.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, Thiele A, van den Born M, Begthel H, Brabletz T. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol. 2005;7:381-386.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Koslowski MJ, Kübler I, Chamaillard M, Schaeffeler E, Reinisch W, Wang G, Beisner J, Teml A, Peyrin-Biroulet L, Winter S. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One. 2009;4:e4496.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Wehkamp J, Harder J, Weichenthal M, Schwab M, Schäffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658-1664.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731-734.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Elphick D, Liddell S, Mahida YR. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol. 2008;172:702-713.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut. 2008;57:903-910.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Kelly P, Feakins R, Domizio P, Murphy J, Bevins C, Wilson J, McPhail G, Poulsom R, Dhaliwal W. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol. 2004;135:303-309.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Wehkamp J, Stange EF. Paneth's disease. J Crohns Colitis. 2010;4:523-531.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Shirazi T, Longman RJ, Corfield AP, Probert CS. Mucins and inflammatory bowel disease. Postgrad Med J. 2000;76:473-478.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001;294:2155-2158.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, Kaestner KH. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development. 2002;129:2619-2628.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature. 2005;435:964-968.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD. Control of endodermal endocrine development by Hes-1. Nat Genet. 2000;24:36-44.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  van Den Brink GR, de Santa Barbara P, Roberts DJ. Development. Epithelial cell differentiation--a Mather of choice. Science. 2001;294:2115-2116.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol. 2007;23:370-378.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol. 2007;81:907-915.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut. 2007;56:1240-1247.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  McCormick DA, Horton LW, Mee AS. Mucin depletion in inflammatory bowel disease. J Clin Pathol. 1990;43:143-146.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 1994;35:353-359.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Rhodes JM. Colonic mucus and ulcerative colitis. Gut. 1997;40:807-808.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr. 2001;73:1131S-1141S.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut. 1997;40:782-789.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117-129.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Pütsep K, Andersson M. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut. 2008;57:764-771.  [PubMed]  [DOI]  [Cited in This Article: ]